Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis.


Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
Historique:
received: 05 10 2019
revised: 19 03 2020
accepted: 17 04 2020
entrez: 27 8 2020
pubmed: 28 8 2020
medline: 8 6 2021
Statut: ppublish

Résumé

Sleep disorders have a high prevalence among patients with idiopathic pulmonary fibrosis (IPF). The prevalence of restless legs syndrome (RLS) is not known in these patients, neither is its clinical impact as a comorbidity. We investigated the association of RLS with IPF and characterized the clinical features of RLS in a cohort of IPF patients. Fifty patients with diagnosis of IPF were prospectively enrolled. RLS was diagnosed using the validated 5-item RLS criteria. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index. The prevalence of RLS in the IPF group was compared to that observed in a group of 293 patients referred for suspect of sleep disorders. The relationships between RLS and clinical parameters were determined using multivariate logistic regression. Prevalence of RLS in the IPF group was significantly higher than in the control population of patients referred for sleep disorders (IPF: 24%, controls 10%: χ RLS is highly prevalent in IPF and significantly worsen sleep quality in these patients. The benefit/risk ratio of a specific therapeutic intervention for RLS in IPF should be assessed in further prospective research.

Identifiants

pubmed: 32843160
pii: S0954-6111(20)30122-0
doi: 10.1016/j.rmed.2020.105982
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105982

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Francesco Varone (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy. Electronic address: francesco.varone@policlinicogemelli.it.

Ludovica Friello (L)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy.

Chiara Di Blasi (C)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy.

Giacomo Sgalla (G)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy.

Marco Luigetti (M)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy.

Bruno Iovene (B)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy.

Luca Richeldi (L)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy; Universit? Cattolica del Sacro Cuore, Rome, Italy.

Giacomo Della Marca (G)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy; Universit? Cattolica del Sacro Cuore, Rome, Italy.

Valerio Brunetti (V)

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Pneumologia, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH